Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

Keywords

Chimeric antigen receptorCD8ImmunologyChronic lymphocytic leukemiaAntigenCytotoxic T cellT cellCancer researchBiologyCD19Immune systemLeukemiaMedicineIn vitro

MeSH Terms

AnimalsAntigensCD19FemaleImmunotherapyAdoptiveInterleukin-6LeukemiaLymphocyticChronicB-CellMaleMiceReceptorsChimeric AntigenSTAT3 Transcription FactorTranscriptionGeneticTreatment Outcome

Affiliated Institutions

Related Publications

Cancer immunotherapy using checkpoint blockade

Antoni Ribas , Jedd D. Wolchok

The release of negative regulators of immune activation (immune checkpoints) that limit antitumor responses has resulted in unprecedented rates of long-lasting tumor responses i...

2018 Science 6236 citations

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan , Shannon J. Turley , Dorothee Nickles +39 more

2018 Nature 5078 citations

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

Peng Jiang , Shengqing Gu , Deng Pan +12 more

2018 Nature Medicine 5230 citations

Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.

Ernest S. Kawasaki , SS Clark , Mazie Coyne +4 more

The Philadelphia chromosome is present in more than 95% of chronic myeloid leukemia patients and 13% of acute lymphocytic leukemia patients. The Philadelphia translocation, t(9;...

1988 Proceedings of the National Academy o... 721 citations

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi , Steven O’Day , David F. McDermott +26 more

Ipilimumab, with or without a gp100 peptide vaccine, as compared with gp100 alone, improved overall survival in patients with previously treated metastatic melanoma. Adverse eve...

2010 New England Journal of Medicine 14794 citations

Publication Info

Year: 2018
Type: article
Volume: 24
Issue: 5
Pages: 563-571
Citations: 1614
Access: Closed

External Links

Download PDF (Free) View on DOI.org PubMed Semantic Scholar

Social Impact

Altmetric

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1614

OpenAlex

Influential

Cite This

APA Style

                            
                                
                                    Joseph A. Fraietta, 
                                
                                    Simon F. Lacey, 
                                
                                    Elena J. Orlando
                                
                                et al.
                            
                            (2018). 
                            Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. 
                            Nature Medicine
                            , 24
                            (5)
                            , 563-571.
                            https://doi.org/10.1038/s41591-018-0010-1
                        

Identifiers

DOI: 10.1038/s41591-018-0010-1
PMID: 29713085
PMCID: PMC6117613

Data Quality

Data completeness: 72%